{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:35:51Z","timestamp":1790994951171,"version":"4.1.0"},"publisher-location":"Cham","reference-count":146,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030573683","type":"print"},{"value":"9783030573690","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-57369-0_1","type":"book-chapter","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T09:26:59Z","timestamp":1608197219000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Constituents of Cannabis Sativa"],"prefix":"10.1007","author":[{"given":"Erin M.","family":"Rock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","volume":"56","author":"A Abrahamov","year":"1995","unstructured":"Abrahamov A, Abrahamov A, Mechoulam R (1995) An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci 56:2097\u20132102","journal-title":"Life Sci"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/clpt.2011.188","volume":"90","author":"DI Abrams","year":"2011","unstructured":"Abrams DI, Couey P, Shade SB et al (2011) Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90:844\u2013851. https:\/\/doi.org\/10.1038\/clpt.2011.188","journal-title":"Clin Pharmacol Ther"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/ja01858a058","volume":"62","author":"R Adams","year":"1940","unstructured":"Adams R, Hunt M, Clark JH (1940) Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. I. J Am Chem Soc 62:196\u2013200. https:\/\/doi.org\/10.1021\/ja01858a058","journal-title":"J Am Chem Soc"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1021\/np070454a","volume":"71","author":"SA Ahmed","year":"2008","unstructured":"Ahmed SA, Ross SA, Slade D et al (2008) Cannabinoid ester constituents from high-potency Cannabis sativa. J Nat Prod 71:536\u2013542. https:\/\/doi.org\/10.1021\/np070454a","journal-title":"J Nat Prod"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.phytochem.2015.04.007","volume":"117","author":"SA Ahmed","year":"2015","unstructured":"Ahmed SA, Ross SA, Slade D et al (2015) Minor oxygenated cannabinoids from high potency Cannabis sativa. Phytochemistry 117:194\u2013199. https:\/\/doi.org\/10.1016\/j.phytochem.2015.04.007","journal-title":"Phytochemistry"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"E691","DOI":"10.3390\/ijms18040691","volume":"18","author":"TB Alberti","year":"2017","unstructured":"Alberti TB, Barbosa WL, Vieira JL et al (2017) (\u2212)-\u03b2-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis. Int J Mol Sci 18:E691. https:\/\/doi.org\/10.3390\/ijms18040691","journal-title":"Int J Mol Sci"},{"key":"1_CR7","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.214","volume":"1","author":"N Amada","year":"2013","unstructured":"Amada N, Yamasaki Y, Williams CM et al (2013) Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. Peer J 1:e214. https:\/\/doi.org\/10.7717\/peerj.214","journal-title":"Peer J"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.pbb.2004.01.015","volume":"77","author":"Y Avraham","year":"2004","unstructured":"Avraham Y, Ben-Shushan D, Breuer A et al (2004) Very low doses of \u03948-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav 77:675\u2013684. https:\/\/doi.org\/10.1016\/j.pbb.2004.01.015","journal-title":"Pharmacol Biochem Behav"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","volume":"19","author":"KA Babson","year":"2017","unstructured":"Babson KA, Sottile J, Morabito D (2017) Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep 19:23. https:\/\/doi.org\/10.1007\/s11920-017-0775-9","journal-title":"Curr Psychiatry Rep"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","volume":"135","author":"A Bahi","year":"2014","unstructured":"Bahi A, Al Mansouri S, Al Memari E et al (2014) \u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav 135:119\u2013124. https:\/\/doi.org\/10.1016\/j.physbeh.2014.06.003","journal-title":"Physiol Behav"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pnpbp.2012.02.006","volume":"38","author":"FR Bambico","year":"2012","unstructured":"Bambico FR, Hattan PR, Garant JP et al (2012) Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission. Prog Neuro-Psychopharmacol Biol Psychiatry 38:88\u201396. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.02.006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-018-0862-2","volume":"19","author":"EP Baron","year":"2018","unstructured":"Baron EP, Lucas P, Eades J et al (2018) Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. J Headache Pain 19:37. https:\/\/doi.org\/10.1186\/s10194-018-0862-2","journal-title":"J Headache Pain"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","volume":"36","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, Queiroz RH, Chagas MH et al (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36:1219\u20131226. https:\/\/doi.org\/10.1038\/npp.2011.6","journal-title":"Neuropsychopharmacology"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2146\/ajhp140523","volume":"72","author":"K Betthauser","year":"2015","unstructured":"Betthauser K, Pilz J, Vollmer LE (2015) Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. Am J Health Syst Pharm 72:1279\u20131284. https:\/\/doi.org\/10.2146\/ajhp140523","journal-title":"Am J Health Syst Pharm"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","volume":"35","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S, Morrison PD, Fusar-Poli P et al (2010) Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35:764\u2013774. https:\/\/doi.org\/10.1038\/npp.2009.184","journal-title":"Neuropsychopharmacology"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocellis L (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845\u2013852. https:\/\/doi.org\/10.1038\/sj.bjp.0704327","journal-title":"Br J Pharmacol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1476-5381.2010.00756.x","volume":"160","author":"D Bolognini","year":"2010","unstructured":"Bolognini D, Costa B, Maione S et al (2010) The plant cannabinoid \u03949-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. Br J Pharmacol 160:677\u2013687. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00756.x","journal-title":"Br J Pharmacol"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/bph.12043","volume":"168","author":"D Bolognini","year":"2013","unstructured":"Bolognini D, Rock EM, Cluny NL et al (2013) Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol 168:1456\u20131470. https:\/\/doi.org\/10.1111\/bph.12043","journal-title":"Br J Pharmacol"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","volume":"85","author":"F Borrelli","year":"2013","unstructured":"Borrelli F, Fasolino I, Romano B et al (2013) Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 85:1306\u20131316. https:\/\/doi.org\/10.1016\/j.bcp.2013.01.017","journal-title":"Biochem Pharmacol"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-59259-947-9_2","volume-title":"Marijuana and the cannabinoids forensic science and medicine","author":"R Brenneisen","year":"2007","unstructured":"Brenneisen R (2007) Chemistry and analysis of phytocannabinoids and other cannabis constituents. In: ElSohly M (ed) Marijuana and the cannabinoids forensic science and medicine. Humana Press, New York, pp 17\u201349"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1007\/s00213-016-4397-4","volume":"233","author":"DI Brierley","year":"2016","unstructured":"Brierley DI, Samuels J, Duncan M et al (2016) Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology 233:3603\u20133613. https:\/\/doi.org\/10.1007\/s00213-016-4397-4","journal-title":"Psychopharmacology"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/FBP.0000000000000285","volume":"28","author":"DI Brierley","year":"2017","unstructured":"Brierley DI, Samuels J, Duncan M et al (2017) A cannabigerol-rich Cannabis sativa extract, devoid of 9-tetrahydrocannabinol, elicits hyperphagia in rats. Behav Pharmacol 28:280\u2013284. https:\/\/doi.org\/10.1097\/FBP.0000000000000285","journal-title":"Behav Pharmacol"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jphp.12845","volume":"70","author":"C Carcieri","year":"2018","unstructured":"Carcieri C, Tomasello C, Simiele M et al (2018) Cannabinoids concentration variability in cannabis olive oil galenic preparations. J Pharm Pharmacol 70:143\u2013149. https:\/\/doi.org\/10.1111\/jphp.12845","journal-title":"J Pharm Pharmacol"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","volume":"159","author":"MG Cascio","year":"2010","unstructured":"Cascio MG, Gauson LA, Stevenson LA et al (2010) Evidence that the plant cannabinoid cannabigerol is a highly potent \u03b12-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br J Pharmacol 159:129\u2013141. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00515.x","journal-title":"Br J Pharmacol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","volume":"28","author":"MH Chagas","year":"2014","unstructured":"Chagas MH, Zuardi AW, Tumas V et al (2014) Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: an exploratory double-blind trial. J Psychopharmacol 28:1088\u20131098. https:\/\/doi.org\/10.1177\/0269881114550355","journal-title":"J Psychopharmacol"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/0003-4819-91-6-819","volume":"91","author":"AE Chang","year":"1979","unstructured":"Chang AE, Shiling DJ, Stillman RC et al (1979) Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Ann Intern Med 91:819\u2013824","journal-title":"Ann Intern Med"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","volume":"231","author":"D Cheng","year":"2014","unstructured":"Cheng D, Low JK, Logge W et al (2014) Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1E9 mice. Psychopharmacology 231:3009\u20133017. https:\/\/doi.org\/10.1007\/s00213-014-3478-5","journal-title":"Psychopharmacology"},{"key":"1_CR28","first-page":"859","volume":"289","author":"DL Cichewicz","year":"1999","unstructured":"Cichewicz DL, Martin ZL, Smith FL et al (1999) Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification. J Pharmacol Exp Ther 289:859\u2013867","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jpba.2016.05.033","volume":"128","author":"C Citti","year":"2016","unstructured":"Citti C, Ciccarella G, Braghiroli D et al (2016) Medicinal cannabis: principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. J Pharm Biomed Anal 128:201\u2013209. https:\/\/doi.org\/10.1016\/j.jpba.2016.05.033","journal-title":"J Pharm Biomed Anal"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1021\/np800740m","volume":"72","author":"MV Cleemput","year":"2009","unstructured":"Cleemput MV, Cattoor K, Bosscher KD et al (2009) Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds. J Nat Prod 72:1220\u20131230. https:\/\/doi.org\/10.1021\/np800740m","journal-title":"J Nat Prod"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1742-7843.2008.00253.x","volume":"103","author":"NL Cluny","year":"2008","unstructured":"Cluny NL, Naylor RJ, Whittle BA et al (2008) The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus. Basic Clin Pharmacol Toxicol 103:150\u2013156. https:\/\/doi.org\/10.1111\/j.1742-7843.2008.00253.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/acprof:oso\/9780199662685.003.0025","volume-title":"Handbook of cannabis","author":"B Costa","year":"2014","unstructured":"Costa B, Comelli F (2014) Pain. In: Pertwee RG (ed) Handbook of cannabis. Oxford University Press, United Kingdom, pp 473\u2013486"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","volume":"25","author":"JA Crippa","year":"2011","unstructured":"Crippa JA, Derenusson GN, Ferrari TB et al (2011) Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol 25:121\u2013130. https:\/\/doi.org\/10.1177\/0269881110379283","journal-title":"J Psychopharmacol"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","volume":"9","author":"JA Crippa","year":"2018","unstructured":"Crippa JA, Guimar\u00e3es FS, Campos AC et al (2018) Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Front Immunol 9:2009. https:\/\/doi.org\/10.3389\/fimmu.2018.02009","journal-title":"Front Immunol"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000137430","volume":"21","author":"JM Cunha","year":"1980","unstructured":"Cunha JM, Carlini EA, Pereira AE et al (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21:175\u2013185","journal-title":"Pharmacology"},{"key":"1_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122392","volume":"18","author":"TC Lima","year":"2017","unstructured":"de C\u00e1ssia da Silveira E S\u00e1 R, Lima TC, da N\u00f3brega FR et al (2017) Analgesic-like activity of essential oil constituents: an update. Int J Mol Sci 18:E2392. https:\/\/doi.org\/10.3390\/ijms18122392","journal-title":"Int J Mol Sci"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1871527317666180420150249","volume":"17","author":"DR de Oliveira","year":"2018","unstructured":"de Oliveira DR, da Silva DM, Florentino IF et al (2018) Monoamine involvement in the antidepressant-like effect of \u03b2-caryophyllene. CNS Neurol Disord Drug Targets 17:309\u2013320. https:\/\/doi.org\/10.2174\/1871527317666180420150249","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS et al (2011) Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163:1479\u20131494. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01166.x","journal-title":"Br J Pharmacol"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","volume":"204","author":"L De Petrocellis","year":"2012","unstructured":"De Petrocellis L, Orlando P, Moriello AS et al (2012) Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol 204:255\u2013266. https:\/\/doi.org\/10.1111\/j.1748-1716.2011.02338.x","journal-title":"Acta Physiol"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1124\/jpet.107.134809","volume":"325","author":"L De Petrocellis","year":"2008","unstructured":"De Petrocellis L, Vellani V, Schiano-Moriello A et al (2008) Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther 325:1007\u20131015. https:\/\/doi.org\/10.1124\/jpet.107.134809","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR41","first-page":"605","volume":"34","author":"WA Devane","year":"1988","unstructured":"Devane WA, Dysarz FA, Johnson MR et al (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605\u2013613","journal-title":"Mol Pharmacol"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946\u20131949","journal-title":"Science"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L et al (2017) Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 376:2011\u20132020. https:\/\/doi.org\/10.1056\/NEJMoa1611618","journal-title":"N Engl J Med"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1749-6632.1971.tb13985.x","volume":"191","author":"H Edery","year":"1971","unstructured":"Edery H, Grunfeld Y, Ben-Zvi Z et al (1971) Structural requirements for cannabinoid activity. Ann N Y Acad Sci 191:40\u201353","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR45","first-page":"1995","volume":"22","author":"H Edery","year":"1972","unstructured":"Edery H, Grunfeld Y, Porath G et al (1972) Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain. Arzneimittelforschung 22:1995\u20132003","journal-title":"Arzneimittelforschung"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/j.1552-4604.1981.tb02576.x","volume":"21","author":"LH Einhorn","year":"1981","unstructured":"Einhorn LH, Nagy C, Furnas B et al (1981) Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. J Clin Pharmacol 21:64\u201369","journal-title":"J Clin Pharmacol"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/acprof:oso\/9780199662685.003.0001","volume-title":"Handbook of cannabis","author":"MA ElSohl","year":"2014","unstructured":"ElSohl MA, Gul W (2014) Constituents of Cannabis sativa. In: Pertwee RG (ed) Handbook of cannabis. Oxford University Press, UK, pp 3\u201322"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S et al (2016) Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States. Biol Psychiatry 79:613\u2013619. https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.004","journal-title":"Biol Psychiatry"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA ElSohly","year":"2005","unstructured":"ElSohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539\u2013548. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.011","journal-title":"Life Sci"},{"issue":"2","key":"1_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/fcp.12416","volume":"33","author":"CFB Felipe","year":"2018","unstructured":"Felipe CFB, Albuquerque AMS, de Pontes JLX et al (2018) Comparative study of alpha- and beta-pinene effect on PTZ-induced convulsions in mice. Fundam Clin Pharmacol 33(2):181\u2013190. https:\/\/doi.org\/10.1111\/fcp.12416","journal-title":"Fundam Clin Pharmacol"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","volume":"78","author":"AI Fraguas-S\u00e1nchez","year":"2018","unstructured":"Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI (2018) Medical use of cannabinoids. Drugs 78:1665\u20131703. https:\/\/doi.org\/10.1007\/s40265-018-0996-1","journal-title":"Drugs"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-91-6-825","volume":"91","author":"S Frytak","year":"1979","unstructured":"Frytak S, Moertel CG, O\u2019Fallon JR et al (1979) Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med 91:825\u2013830","journal-title":"Ann Intern Med"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646\u20131647","journal-title":"J Am Chem Soc"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S et al (2008) Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A 105:9099\u20139104. https:\/\/doi.org\/10.1073\/pnas.0803601105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1039\/j39710000579","volume":"0","author":"EW Gill","year":"1971","unstructured":"Gill EW (1971) Propyl homologue of tetrahydrocannabinol: its isolation from cannabis, properties, and synthesis. J Chem Soc, Section C: Organic 0:579\u2013582","journal-title":"J Chem Soc, Section C: Organic"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/BF00404218","volume":"14","author":"Y Grunfeld","year":"1969","unstructured":"Grunfeld Y, Edery H (1969) Psychopharmacological activity of the active constituents of hashish and some related cannabinoids. Psychopharmacologia 14:200\u2013210","journal-title":"Psychopharmacologia"},{"key":"1_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19071992","volume":"19","author":"A Gugliandolo","year":"2018","unstructured":"Gugliandolo A, Pollastro F, Grassi G et al (2018) In vitro model of neuroinflammation: efficacy of cannabigerol, a non-psychoactive cannabinoid. Int J Mol Sci 19:E1992. https:\/\/doi.org\/10.3390\/ijms19071992","journal-title":"Int J Mol Sci"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02244012","volume":"100","author":"FS Guimar\u00e3es","year":"1990","unstructured":"Guimar\u00e3es FS, Chiaretti TM, Graeff FG et al (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100:558\u2013559. https:\/\/doi.org\/10.1007\/BF02244012","journal-title":"Psychopharmacology"},{"key":"1_CR59","first-page":"161","volume":"74","author":"L Hanu\u0161","year":"1975","unstructured":"Hanu\u0161 L, Krej\u010d\u00ed Z (1975) Isolation of two new cannabinoid acids from Cannabis sativa L. of Czechoslovak origin. Acta Univ Olomuc Fac Med 74:161\u2013166","journal-title":"Acta Univ Olomuc Fac Med"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJM197906073002302","volume":"300","author":"TS Herman","year":"1979","unstructured":"Herman TS, Einhorn LH, Jones SE et al (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300:1295\u20131297","journal-title":"N Engl J Med"},{"key":"1_CR61","first-page":"331","volume":"27","author":"TS Herman","year":"1977","unstructured":"Herman TS, Jones SE, Dean J et al (1977) Nabilone: a potent antiemetic cannabinol with minimal euphoria. Biomedicine 27:331\u2013334","journal-title":"Biomedicine"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bph.12321","volume":"170","author":"TD Hill","year":"2013","unstructured":"Hill TD, Cascio MG, Romano B et al (2013) Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol 170:679\u2013692. https:\/\/doi.org\/10.1111\/bph.12321","journal-title":"Br J Pharmacol"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejphar.2004.06.069","volume":"499","author":"MN Hill","year":"2004","unstructured":"Hill MN, Gorzalka BB (2004) Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress. Eur J Pharmacol 499:291\u2013295. https:\/\/doi.org\/10.1016\/j.ejphar.2004.06.069","journal-title":"Eur J Pharmacol"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","volume":"167","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Mercier MS, Hill TD et al (2012) Cannabidivarin is anticonvulsant in mouse and rat. Br J Pharmacol 167:1629\u20131642. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02207.x","journal-title":"Br J Pharmacol"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1021\/ja00960a056","volume":"88","author":"RL Hively","year":"1966","unstructured":"Hively RL, Mosher WA, Hoffmann FW (1966) Isolation of trans-\u03946-tetrahydrocannabinol from marijuana. J Am Chem Soc 88:1832\u20131833","journal-title":"J Am Chem Soc"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000136462","volume":"11","author":"LE Hollister","year":"1974","unstructured":"Hollister LE (1974) Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol. Pharmacology 11:3\u201311","journal-title":"Pharmacology"},{"key":"1_CR67","first-page":"307","volume":"29","author":"AC Howlett","year":"1986","unstructured":"Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307\u2013313","journal-title":"Mol Pharmacol"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","volume":"7","author":"JW Huffman","year":"1999","unstructured":"Huffman JW, Liddle J, Yu S et al (1999) 3-(1\u2032,1\u2032-Dimethylbutyl)-1-deoxy-\u03948-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem 7:2905\u20132914","journal-title":"Bioorg Med Chem"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1007\/s00044-014-0972-6","volume":"23","author":"AS Husni","year":"2014","unstructured":"Husni AS, McCurdy CR, Radwan MM et al (2014) Evaluation of phytocannabinoids from high potency Cannabis sativa using in vitro bioassays to determine structure-activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2. Med Chem Res 23:4295\u20134300. https:\/\/10.1007\/s00044-014-0972-6","journal-title":"Med Chem Res"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","volume":"30","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Borrelli F, Capasso R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515\u2013527. https:\/\/10.1016\/j.tips.2009.07.00","journal-title":"Trends Pharmacol Sci"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1037\/pha0000081","volume":"24","author":"DS Jacobs","year":"2016","unstructured":"Jacobs DS, Kohut SJ, Jiang S et al (2016) Acute and chronic effects of cannabidiol on \u03949-tetrahydrocannabinol (\u03949-THC)-induced disruption in stop signal task performance. Exp Clin Psychopharmacol 24:320\u2013330. https:\/\/10.1037\/pha0000081","journal-title":"Exp Clin Psychopharmacol"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1476-5381.2010.00791.x","volume":"160","author":"JM Jamontt","year":"2010","unstructured":"Jamontt JM, Molleman A, Pertwee RG et al (2010) The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Br J Pharmacol 160:712\u2013723. https:\/\/10.1111\/j.1476-5381.2010.00791.x","journal-title":"Br J Pharmacol"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","volume":"51","author":"R Jetly","year":"2015","unstructured":"Jetly R, Heber A, Fraser G et al (2015) The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology 51:585\u2013588. https:\/\/10.1016\/j.psyneuen.2014.11.002","journal-title":"Psychoneuroendocrinology"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881110385594","volume":"25","author":"DO Kennedy","year":"2011","unstructured":"Kennedy DO, Dodd FL, Robertson BC et al (2011) Monoterpenoid extract of sage (salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. J Psychopharmacol 25:1088\u20131100. https:\/\/10.1177\/0269881110385594","journal-title":"J Psychopharmacol"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1142\/S0192415X15500457","volume":"43","author":"DS Kim","year":"2015","unstructured":"Kim DS, Lee HJ, Jeon YD et al (2015) Alpha-pinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-\u03baB pathway in mouse peritoneal macrophages. Am J Chin Med 43:731\u2013742. https:\/\/10.1142\/S0192415X15500457","journal-title":"Am J Chin Med"},{"key":"1_CR76","first-page":"174","volume":"2","author":"T Komori","year":"1995","unstructured":"Komori T, Fujiwara R, Tanida M et al (1995) Effects of citrus fragrance on immune function and depressive states. Neuroimmunology 2:174\u2013180. https:\/\/10.1159\/000096889","journal-title":"Neuroimmunology"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0006-8993(99)02422-1","volume":"857","author":"DF Louw","year":"2000","unstructured":"Louw DF, Yang FW, Sutherland GR (2000) The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat. Brain Res 857:183\u2013187. https:\/\/doi.org\/10.1016\/S0006-8993(99)02422-1","journal-title":"Brain Res"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0885-3924(03)00142-8","volume":"25","author":"ME Lynch","year":"2003","unstructured":"Lynch ME, Clark AJ (2003) Cannabis reduces opioid dose in the treatment of chronic non-cancer pain. J Pain Symptom Manag 25:496\u2013498. https:\/\/doi.org\/10.1016\/S0885-3924(03)00142-8","journal-title":"J Pain Symptom Manag"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","volume":"40","author":"BR Martin","year":"1991","unstructured":"Martin BR, Compton DR, Thomas BF et al (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471\u2013478","journal-title":"Pharmacol Biochem Behav"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","volume":"175","author":"P McGuire","year":"2018","unstructured":"McGuire P, Robson P, Cubala WJ et al (2018) Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial. Am J Psychiatry 175:225\u2013231. https:\/\/doi.org\/10.1176\/appi.ajp.2017.17030325","journal-title":"Am J Psychiatry"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/can.2016.0032","volume":"2","author":"JM McPartland","year":"2017","unstructured":"McPartland JM, MacDonald C, Young M et al (2017) Affinity and efficacy studies of tetrahydrocannabinolic acid a at cannabinoid receptor types one and two. Cannabis Cannabinoid Res 2:87\u201395. https:\/\/10.1089\/can.2016.0032","journal-title":"Cannabis Cannabinoid Res"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1300\/J175v01n03_08","volume":"1","author":"JM McPartland","year":"2001","unstructured":"McPartland JM, Russo EB (2001) Cannabis and cannabis extracts: greater than the sum of their parts? J Cann Therap 1:103\u2013132. https:\/\/doi.org\/10.1300\/J175v01n03_08","journal-title":"J Cann Therap"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.bjp.0706415","volume":"146","author":"R Mechoulam","year":"2005","unstructured":"Mechoulam R (2005) Plant cannabinoids: a neglected pharmacological treasure trove. Br J Pharmacol 146:913\u2013915. https:\/\/doi.org\/10.1038\/sj.bjp.0706415","journal-title":"Br J Pharmacol"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83\u201390. https:\/\/doi.org\/10.1016\/0006-2952(95)00109-D","journal-title":"Biochem Pharmacol"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/S0040-4039(01)88158-2","volume":"28","author":"R Mechoulam","year":"1969","unstructured":"Mechoulam R, Ben-Zvi Z, Yagnitinsky B et al (1969) A new tetrahydrocannabinolic acid. Tetrahedron Lett 28:2339\u20132341","journal-title":"Tetrahedron Lett"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrn3811","volume":"15","author":"R Mechoulam","year":"2014","unstructured":"Mechoulam R, Hanus LO, Pertwee R et al (2014) Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat Rev Neurosci 15:757\u2013764. https:\/\/doi.org\/10.1038\/nrn3811","journal-title":"Nat Rev Neurosci"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.169.3945.611","volume":"169","author":"R Mechoulam","year":"1970","unstructured":"Mechoulam R, Shani A, Edery H et al (1970) Chemical basis of hashish activity. Science 169:611\u2013612","journal-title":"Science"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","volume":"19","author":"R Mechoulam","year":"1963","unstructured":"Mechoulam R, Shvo Y (1963) Hashish. I. the structure of cannabidiol. Tetrahedron 19:2073\u20132078","journal-title":"Tetrahedron"},{"key":"1_CR89","first-page":"16","volume":"5","author":"C Meier","year":"1998","unstructured":"Meier C, Mediavilla V (1998) Factors influencing the yield and the quality of hemp (Cannabis sativa L.) essential oil. J Int Hemp Assoc 5:16\u201320","journal-title":"J Int Hemp Assoc"},{"key":"1_CR90","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/232579a0","volume":"232","author":"FWHM Merkus","year":"1971","unstructured":"Merkus FWHM (1971) Cannabivarin and tetrahydrocannabivarin, two new constituents of hashish. Nature 232:579\u2013580","journal-title":"Nature"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0021-9673(01)91388-3","volume":"199","author":"F Merli","year":"1980","unstructured":"Merli F, Novotny M, Lee ML (1980) Fractionation and gas chromatographic analysis of aza-arenes in complex mixtures. J Chromatogr 199:371\u2013378. https:\/\/doi.org\/10.1016\/S0021-9673(01)91388-3","journal-title":"J Chromatogr"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-45541-9_4","volume":"103","author":"P Morales","year":"2017","unstructured":"Morales P, Hurst DP, Reggio PH (2017) Molecular targets of the phytocannabinoids: a complex picture. Prog Chem Org Nat Prod 103:103\u2013131. https:\/\/doi.org\/10.1007\/978-3-319-45541-9_4","journal-title":"Prog Chem Org Nat Prod"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/can.2016.0008","volume":"1","author":"G Moreno-Sanz","year":"2016","unstructured":"Moreno-Sanz G (2016) Can you pass the acid test? Critical review and novel therapeutic perspectives of \u03949-tetrahydrocannabinolic acid a. Cannabis Cannabinoid Res 1:124\u2013130. https:\/\/doi.org\/10.1089\/can.2016.0008","journal-title":"Cannabis Cannabinoid Res"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2002-25028","volume":"3","author":"KR M\u00fcller-Vahl","year":"2002","unstructured":"M\u00fcller-Vahl KR, Schneider U, Koblenz A et al (2002) Treatment of Tourette\u2019s syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry 3:57\u201361. https:\/\/doi.org\/10.1055\/s-2002-25028","journal-title":"Pharmacopsychiatry"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4088\/JCP.v64n0417","volume":"64","author":"KR M\u00fcller-Vahl","year":"2003","unstructured":"M\u00fcller-Vahl KR, Schneider U, Prevedel H et al (2003) Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6- week randomized trial. J Clin Psychiatry 64:459\u2013465","journal-title":"J Clin Psychiatry"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365. https:\/\/doi.org\/10.1038\/365061a0","journal-title":"Nature"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/082585979401000105","volume":"10","author":"K Nelson","year":"1994","unstructured":"Nelson K, Walsh D, Deeter P et al (1994) A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care 10:14\u201318","journal-title":"J Palliat Care"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.pbb.2012.10.008","volume":"103","author":"LD O\u2019Brien","year":"2013","unstructured":"O\u2019Brien LD, Wills KL, Segsworth B et al (2013) Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. Pharmacol Biochem Behav 103:597\u2013602. https:\/\/doi.org\/10.1016\/j.pbb.2012.10.008","journal-title":"Pharmacol Biochem Behav"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00213-003-1571-2","volume":"171","author":"LA Parker","year":"2004","unstructured":"Parker LA, Kwiatkowska M, Burton P et al (2004) Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology 171:156\u2013161. https:\/\/doi.org\/10.1007\/s00213-003-1571-2","journal-title":"Psychopharmacology"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00213-002-1329-2","volume":"166","author":"LA Parker","year":"2003","unstructured":"Parker LA, Mechoulam R, Schlievert C et al (2003) Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacology 166:156\u2013162. https:\/\/doi.org\/10.1007\/s00213-002-1329-2","journal-title":"Psychopharmacology"},{"issue":"29","key":"1_CR101","first-page":"32","volume":"2","author":"DW Pate","year":"1994","unstructured":"Pate DW (1994) Chemical ecology of cannabis. J Int Hemp Association 2(29):32\u201337","journal-title":"J Int Hemp Association"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1467-9566.2012.01476.x","volume":"35","author":"W Pedersen","year":"2013","unstructured":"Pedersen W, Sandberg S (2013) The medicalisation of revolt: a sociological analysis of medical cannabis users. Sociol Health Illn 35:17\u201332. https:\/\/doi.org\/10.1111\/j.1467-9566.2012.01476.x","journal-title":"Sociol Health Illn"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00228-018-2516-3","volume":"74","author":"L Pellesi","year":"2018","unstructured":"Pellesi L, Licata M, Verri P et al (2018) Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)\u2014a pilot study. Eur J Clin Pharmacol 74:1427\u20131436. https:\/\/doi.org\/10.1007\/s00228-018-2516-3","journal-title":"Eur J Clin Pharmacol"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1476-5381.1972.tb06900.x","volume":"46","author":"RG Pertwee","year":"1972","unstructured":"Pertwee RG (1972) The ring test: a quantitative method for assessing the \u2018cataleptic\u2019 effect of cannabis in mice. Br J Pharmacol 46:753\u2013763","journal-title":"Br J Pharmacol"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","volume":"76","author":"RG Pertwee","year":"2005","unstructured":"Pertwee RG (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 76:1307\u20131324. https:\/\/doi.org\/10.1016\/j.lfs.2004.10.025","journal-title":"Life Sci"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br J Pharmacol 153:199\u2013215. https:\/\/doi.org\/10.1038\/sj.bjp.0707442","journal-title":"Br J Pharmacol"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/sj.bjp.0707124","volume":"150","author":"RG Pertwee","year":"2007","unstructured":"Pertwee RG, Thomas A, Stevenson LA et al (2007) The psychoactive plant cannabinoid, delta9-tetrahydrocannabinol, is antagonized by delta8- and delta9- tetrahydrocannabivarin in mice in vivo. Br J Pharmacol 150:586\u2013594. https:\/\/doi.org\/10.1038\/sj.bjp.0707124","journal-title":"Br J Pharmacol"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/14660820310016813","volume":"5","author":"C Raman","year":"2004","unstructured":"Raman C, McAllister SD, Rizvi G (2004) Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord 5:33\u201339. https:\/\/doi.org\/10.1080\/14660820310016813","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"1_CR109","first-page":"75","volume":"38","author":"RK Razdan","year":"1986","unstructured":"Razdan RK (1986) Structure-activity relationships in cannabinoids. Pharmacol Rev 38:75\u2013149","journal-title":"Pharmacol Rev"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1476-5381.2008.00107.x","volume":"156","author":"G Riedel","year":"2009","unstructured":"Riedel G, Fadda P, McKillop-Smith S (2009) Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Br J Pharmacol 156:1154\u20131166. https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00107.x","journal-title":"Br J Pharmacol"},{"key":"1_CR111","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","volume":"165","author":"EM Rock","year":"2012","unstructured":"Rock EM, Bolognini D, Limebeer CL et al (2012) Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 165:2620\u20132634. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01621.x","journal-title":"Br J Pharmacol"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00213-016-4378-7","volume":"233","author":"EM Rock","year":"2016","unstructured":"Rock EM, Connolly C, Limebeer CL et al (2016) Effect of combined oral doses of \u0394(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models. Psychopharmacology 233:3353\u20133360. https:\/\/doi.org\/10.1007\/s00213-016-4378-7","journal-title":"Psychopharmacology"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00213-010-2157-4","volume":"215","author":"EM Rock","year":"2011","unstructured":"Rock EM, Goodwin JM, Limebeer CL et al (2011) Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology 215:505\u2013512. https:\/\/doi.org\/10.1007\/s00213-010-2157-4","journal-title":"Psychopharmacology"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/bph.12316","volume":"170","author":"EM Rock","year":"2013","unstructured":"Rock EM, Kopstick RL, Limebeer CL et al (2013a) Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. Br J Pharmacol 170:641\u2013648. https:\/\/doi.org\/10.1111\/bph.12316","journal-title":"Br J Pharmacol"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s00213-014-3498-1","volume":"231","author":"EM Rock","year":"2014","unstructured":"Rock EM, Limebeer CL, Navaratnam R (2014a) A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. Psychopharmacology 231:3207\u20133215. https:\/\/doi.org\/10.1007\/s00213-014-3498-1","journal-title":"Psychopharmacology"},{"key":"1_CR116","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00221-014-3942-9","volume":"232","author":"EM Rock","year":"2014","unstructured":"Rock EM, Limebeer CL, Parker LA (2014b) Anticipatory nausea in animal models: a review of potential novel therapeutic treatments. Exp Brain Res 232:2511\u20132534. https:\/\/doi.org\/10.1007\/s00221-014-3942-9","journal-title":"Exp Brain Res"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1007\/s00213-015-4080-1","volume":"232","author":"EM Rock","year":"2015","unstructured":"Rock EM, Limebeer CL, Parker LA (2015) Effect of combined doses of \u0394(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague-Dawley) models of conditioned gaping. Psychopharmacology 232:4445\u20134454. https:\/\/doi.org\/10.1007\/s00213-015-4080-1","journal-title":"Psychopharmacology"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s00213-018-5034-1","volume":"235","author":"EM Rock","year":"2018","unstructured":"Rock EM, Limebeer CL, Parker LA (2018) Effect of cannabidiolic acid and \u03949-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain. Psychopharmacology 235:3259\u20133271. https:\/\/doi.org\/10.1007\/s00213-018-5034-1","journal-title":"Psychopharmacology"},{"key":"1_CR119","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","volume":"234","author":"EM Rock","year":"2017","unstructured":"Rock EM, Limebeer CL, Petrie GN et al (2017) Effect of prior foot shock stress and \u03949-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats. Psychopharmacology 234:2207\u20132217. https:\/\/doi.org\/10.1007\/s00213-017-4626-5","journal-title":"Psychopharmacology"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1037\/bne0000057","volume":"129","author":"EM Rock","year":"2015","unstructured":"Rock EM, Parker LA (2015) Synergy between cannabidiol, cannabidiolic acid, and \u03949-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew). Behav Neurosci 129:368\u2013370. https:\/\/doi.org\/10.1037\/bne0000057","journal-title":"Behav Neurosci"},{"key":"1_CR121","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/bph.12322","volume":"170","author":"EM Rock","year":"2013","unstructured":"Rock EM, Sticht MA, Duncan M et al (2013b) Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and \u0394(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. Br J Pharmacol 170:671\u2013678. https:\/\/doi.org\/10.1111\/bph.12322","journal-title":"Br J Pharmacol"},{"key":"1_CR122","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","volume":"46","author":"S Rosenthaler","year":"2014","unstructured":"Rosenthaler S, P\u00f6hn B, Kolmanz C et al (2014) Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicol Teratol 46:49\u201356. https:\/\/doi.org\/10.1016\/j.ntt.2014.09.003","journal-title":"Neurotoxicol Teratol"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1095-8339.2005.00417.x","volume":"147","author":"M Rothschild","year":"2005","unstructured":"Rothschild M, Bergstrom G, Wangberg S (2005) Cannabis sativa: volatile compounds from pollen and entire male and female plants of two variants, northern lights and Hawaian Indica. Bot J Linn Soc 147:387\u2013397. https:\/\/doi.org\/1111\/j.1095-8339.2005.00417.x","journal-title":"Bot J Linn Soc"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"EB Russo","year":"2011","unstructured":"Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 163:1344\u20131364. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01238.x","journal-title":"Br J Pharmacol"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B et al (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30:1037\u20131043. https:\/\/doi.org\/10.1007\/s11064-005-6978-1","journal-title":"Neurochem Res"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuropharm.2017.07.015","volume":"125","author":"GC Segat","year":"2017","unstructured":"Segat GC, Manjavachi MN, Matias DO et al (2017) Antiallodynic effect of \u03b2-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology 125:207\u2013219. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.015","journal-title":"Neuropharmacology"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13205-014-0220-2","volume":"5","author":"B Singh","year":"2015","unstructured":"Singh B, Sharma R (2015) Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications. 3 Biotech 5:129\u2013151. https:\/\/doi.org\/10.1007\/s13205-014-0220-2","journal-title":"3 Biotech"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0091-3057(73)90005-1","volume":"1","author":"PO Sj\u00f6d\u00e9n","year":"1973","unstructured":"Sj\u00f6d\u00e9n PO, J\u00e4rbe TU, Henriksson BG (1973) Influence of tetrahydrocannabinols (delta8-THC and delta9-THC) on body weight, food, and water intake in rats. Pharmacol Biochem Behav 1:395\u2013399","journal-title":"Pharmacol Biochem Behav"},{"key":"1_CR129","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.2042-7158.1977.tb11313.x","volume":"29","author":"RN Smith","year":"1977","unstructured":"Smith RN, Vaughan CG (1977) The decomposition of acidic and neutral cannabinoids in organic solvents. J Pharm Pharmacol 29:286\u2013290","journal-title":"J Pharm Pharmacol"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A et al (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89\u201397. https:\/\/doi.org\/10.1006\/bbrc.1995.2437","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/epi.14477","volume":"59","author":"JP Szaflarski","year":"2018","unstructured":"Szaflarski JP, Bebin EM, Comi AM et al (2018) Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: expanded access program results. Epilepsia 59:1540\u20131548. https:\/\/doi.org\/10.1111\/epi.14477","journal-title":"Epilepsia"},{"key":"1_CR132","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.toxlet.2012.08.029","volume":"214","author":"S Takeda","year":"2012","unstructured":"Takeda S, Okajima S, Miyoshi H et al (2012) Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Toxicol Lett 214:314\u2013319. https:\/\/doi.org\/10.1016\/j.toxlet.2012.08.029","journal-title":"Toxicol Lett"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.03.009","volume":"57","author":"J Tchekalarova","year":"2011","unstructured":"Tchekalarova J, da Concei\u00e7\u00e3o MK, Gomes J\u00fanior AL et al (2011) Pharmacological characterization of the cannabinoid receptor 2 agonist, \u03b2-caryophyllene on seizure models in mice. Seizure 57:22\u201326. https:\/\/doi.org\/10.1016\/j.seizure.2018.03.009","journal-title":"Seizure"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"GL Thomas","year":"2007","unstructured":"Thomas GL, Baillie AM, Phillips RK et al (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150:613\u2013623. https:\/\/doi.org\/10.1038\/sj.bjp.0707133","journal-title":"Br J Pharmacol"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0099-2399(97)80346-9","volume":"23","author":"M Uemura","year":"1997","unstructured":"Uemura M, Hata GI, Toda T et al (1997) Effectiveness of eucalyptol and d-limonene as gutta-percha solvents. J Endod 23:739\u2013741. https:\/\/doi.org\/10.1016\/S0099-2399(97)80346-9","journal-title":"J Endod"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","volume":"12","author":"S Valdeolivas","year":"2015","unstructured":"Valdeolivas S, Navarrete C, Cantarero I (2015) Neuroprotective properties of cannabigerol in Huntington\u2019s disease: studies in r6\/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics 12:185\u2013199. https:\/\/doi.org\/10.1007\/s13311-014-0304-z","journal-title":"Neurotherapeutics"},{"key":"1_CR137","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.euroneuro.2007.11.003","volume":"18","author":"SA van Vliet","year":"2008","unstructured":"van Vliet SA, Vanwersch RA, Jongsma MJ et al (2008) Therapeutic effects of delta9-THC and modafinil in a marmoset Parkinson model. Eur Neuropsychopharmacol 18:383\u2013389. https:\/\/doi.org\/10.1016\/j.euroneuro.2007.11.003","journal-title":"Eur Neuropsychopharmacol"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.intimp.2005.10.002","volume":"6","author":"KC Verhoeckx","year":"2006","unstructured":"Verhoeckx KC, Korthout HA, van Meeteren-Kreikamp AP (2006) Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. Int Immunopharmacol 6:656\u2013665. https:\/\/doi.org\/10.1016\/j.intimp.2005.10.002","journal-title":"Int Immunopharmacol"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2018.07.029","volume":"140","author":"D Vigli","year":"2018","unstructured":"Vigli D, Cosentino L, Raggi C et al (2018) Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome. Neuropharmacology 140:121\u2013129. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.029","journal-title":"Neuropharmacology"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"E694","DOI":"10.1503\/cmaj.091414","volume":"182","author":"MA Ware","year":"2010","unstructured":"Ware MA, Wang T, Shapiro S et al (2010) Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 182:E694\u2013E701. https:\/\/doi.org\/10.1503\/cmaj.091414","journal-title":"CMAJ"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","volume":"14","author":"B Wilsey","year":"2013","unstructured":"Wilsey B, Marcotte T, Deutsch R et al (2013) Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 14:136\u2013148. https:\/\/doi.org\/10.1016\/j.jpain.2012.10.009","journal-title":"J Pain"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","volume":"9","author":"B Wilsey","year":"2008","unstructured":"Wilsey B, Marcotte T, Tsodikov A et al (2008) A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 9:506\u2013521. https:\/\/doi.org\/10.1016\/j.jpain.2007.12.010","journal-title":"J Pain"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fnins.2017.00583","volume":"11","author":"M Yang","year":"2017","unstructured":"Yang M, Lv Y, Tian X et al (2017) Neuroprotective effect of \u03b2-caryophyllene on cerebral ischemia-reperfusion injury via regulation of necroptotic neuronal death and inflammation: in vivo and in vitro. Front Neurosci 11:583. https:\/\/doi.org\/10.3389\/fnins.2017.00583","journal-title":"Front Neurosci"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.phymed.2013.12.004","volume":"21","author":"J Yun","year":"2014","unstructured":"Yun J (2014) Limonene inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal function and dopamine release. Phytomedicine 21:883\u2013887. https:\/\/doi.org\/10.1016\/j.phymed.2013.12.004","journal-title":"Phytomedicine"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","volume":"159","author":"TV Zanelati","year":"2010","unstructured":"Zanelati TV, Biojone C, Moreira FA et al (2010) Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol 159:122\u2013128. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00521.x","journal-title":"Br J Pharmacol"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000479863","volume":"63","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Chen R, Wang Y et al (2018) \u03b1-Pinene inhibits human prostate cancer growth in a mouse xenograft model. Chemotherapy 63:1\u20137. https:\/\/doi.org\/10.1159\/000479863","journal-title":"Chemotherapy"}],"container-title":["Advances in Experimental Medicine and Biology","Cannabinoids and Neuropsychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-57369-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T03:07:14Z","timestamp":1674788834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-57369-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"ISBN":["9783030573683","9783030573690"],"references-count":146,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-57369-0_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]},"assertion":[{"value":"18 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}